Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pulmonary Hypertension

  Free Subscription


Articles published in Am J Respir Crit Care Med

Retrieve available abstracts of 87 articles:
HTML format
Text format



Single Articles


    December 2018
  1. SUNDD P, Kuebler WM
    Smooth Muscle Cells: A Novel Site of P-selectin Expression with Pathophysiological and Therapeutic Relevance in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Dec 28. doi: 10.1164/rccm.201812-2242.
    PubMed     Text format    


  2. NOVOYATLEVA T, Kojonazarov B, Owczarek A, Veeroju S, et al
    Evidence for Fucoidan-P-selectin Axis as a Therapeutic Target on Hypoxia-induced Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Dec 17. doi: 10.1164/rccm.201806-1170.
    PubMed     Text format     Abstract available


  3. MULLIN CJ, Kato GJ, Ventetuolo CE
    Anakinra, What is Thy Bidding in Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2018 Dec 12. doi: 10.1164/rccm.201811-2192.
    PubMed     Text format    


    September 2018
  4. GRUNIG G, Durmus N
    An RNA Sensor Protects from Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Sep 25. doi: 10.1164/rccm.201807-1363.
    PubMed     Text format    


  5. FARKAS D, Thompson AAR, Bhagwani AR, Hultman S, et al
    Toll-like Receptor 3 is a Therapeutic Target for Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Sep 13. doi: 10.1164/rccm.201707-1370.
    PubMed     Text format     Abstract available


    August 2018
  6. SOFER A, Lee S, Papangeli I, Adachi T, et al
    Therapeutic Engagement of the HDAC IIA-MEF2 Axis Improves Experimental Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Aug 14. doi: 10.1164/rccm.201805-0817.
    PubMed     Text format    


    July 2018
  7. SHIMODA LA
    What's HIF Got to Do with It? HIF-2 Inhibition and Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Jul 12. doi: 10.1164/rccm.201806-1130.
    PubMed     Text format    


    June 2018
  8. ELINOFF JM, Humbert M, Solomon MA
    Reply to: The Light at the End of the Long Pulmonary Hypertension Tunnel Brightens.
    Am J Respir Crit Care Med. 2018 Jun 26. doi: 10.1164/rccm.201804-0792.
    PubMed     Text format    


  9. VOELKEL NF, Newman JH
    The Light at the End of the Long Pulmonary Hypertension Tunnel Brightens.
    Am J Respir Crit Care Med. 2018 Jun 26. doi: 10.1164/rccm.201802-0325.
    PubMed     Text format    


    May 2018
  10. GONCHAROV DA, Goncharova EA, Tofovic SP, Hu J, et al
    Metformin Therapy for Pulmonary Hypertension Associated with HFpEF versus PAH.
    Am J Respir Crit Care Med. 2018 May 4. doi: 10.1164/rccm.201801-0022.
    PubMed     Text format    


    April 2018
  11. STENMARK KR, Hu CJ, Pullamsetti SS
    How Many Foxs Are There on the Road to Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2018 Apr 25. doi: 10.1164/rccm.201804-0702.
    PubMed     Text format    


  12. DAI Z, Zhu MM, Peng Y, Jin H, et al
    Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Apr 17. doi: 10.1164/rccm.201709-1835.
    PubMed     Text format     Abstract available


  13. AGARWAL MA, Shah M, Patel B, Nolan VG, et al
    Association between Pulmonary Hypertension and Clinical Outcomes in Hospitalized Sickle Cell Disease Patients.
    Am J Respir Crit Care Med. 2018 Apr 12. doi: 10.1164/rccm.201802-0261.
    PubMed     Text format    


  14. HU Y, Zabini D, Gu W, Goldenberg NM, et al
    The Role of the Human Immune System in Chronic Hypoxic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Apr 9. doi: 10.1164/rccm.201711-2175.
    PubMed     Text format    


    March 2018
  15. WEST JD, Carrier EJ
    Precision Modeling of Pulmonary Hypertension Pathology with iPSC-derived Cells.
    Am J Respir Crit Care Med. 2018 Mar 29. doi: 10.1164/rccm.201803-0480.
    PubMed     Text format    


  16. BARNES JW, Patel RP
    Things We 'kNOw' and Don't 'kNOw' About Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Mar 28. doi: 10.1164/rccm.201803-0424.
    PubMed     Text format    


  17. ZHANG J, Dong J, Martin M, He M, et al
    AMPK Phosphorylation of ACE2 in Endothelium Mitigates Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Mar 23. doi: 10.1164/rccm.201712-2570.
    PubMed     Text format     Abstract available


    February 2018
  18. OGOSHI T, Tsutsui M, Kido T, Sakanashi M, et al
    Protective Role of Myelocytic Nitric Oxide Synthases Against Hypoxic Pulmonary Hypertension in Mice.
    Am J Respir Crit Care Med. 2018 Feb 26. doi: 10.1164/rccm.201709-1783.
    PubMed     Text format     Abstract available



  19. Chronic Thromboembolic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018;197:P5-P6.
    PubMed     Text format    


  20. LEARY PJ, Hess E, Baron AE, Branch KR, et al
    H2-receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program.
    Am J Respir Crit Care Med. 2018 Feb 13. doi: 10.1164/rccm.201801-0048.
    PubMed     Text format    


  21. ELINOFF JM, Agarwal R, Barnett CF, Benza RL, et al
    Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg.
    Am J Respir Crit Care Med. 2018 Feb 9. doi: 10.1164/rccm.201710-2093.
    PubMed     Text format     Abstract available


    January 2018
  22. BARMAN SA, Chen F, Li X, Haigh S, et al
    Galectin-3 Promotes Vascular Remodeling and Contributes to Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Jan 24. doi: 10.1164/rccm.201711-2308.
    PubMed     Text format    


  23. PRINS KW, Rose L, Archer SL, Pritzker M, et al
    Disproportionate Right Ventricular Dysfunction and Poor Survival in Group 3 Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Jan 23. doi: 10.1164/rccm.201712-2405.
    PubMed     Text format    


    December 2017
  24. MARON BA, Wertheim BM, Gladwin MT
    Under Pressure to Clarify Pulmonary Hypertension Clinical Risk.
    Am J Respir Crit Care Med. 2017 Dec 7. doi: 10.1164/rccm.201711-2306.
    PubMed     Text format    


  25. ZHANG HD, Lv ZC, Wang LT, Rothman A, et al
    Prognostic Significance of Reduced Blood Pressure Response to Exercise in Pediatric Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;196:1478-1481.
    PubMed     Text format    


    November 2017
  26. ROMAN BL, Cuttica MJ
    Classifying Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia. Hemodynamics Matter.
    Am J Respir Crit Care Med. 2017;196:1244-1246.
    PubMed     Text format    


  27. CHUN HJ, Bonnet S, Chan SY
    Reply: Transforming Growth Factor beta1- and Bone Morphogenetic Protein 2/PPARgamma-regulated MicroRNAs in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;196:1228-1229.
    PubMed     Text format    


  28. CALVIER L, Chouvarine P, Legchenko E, Hansmann G, et al
    Transforming Growth Factor beta1- and Bone Morphogenetic Protein 2/PPARgamma-regulated MicroRNAs in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;196:1227-1228.
    PubMed     Text format    


    October 2017

  29. Pulmonary Hypertension in Children.
    Am J Respir Crit Care Med. 2017;196:P15-P16.
    PubMed     Text format    


  30. TALWAR A, Garcia JGN, Tsai H, Moreno M, et al
    Health Disparities in Patients with Pulmonary Arterial Hypertension: A Blueprint for Action. An Official American Thoracic Society Statement.
    Am J Respir Crit Care Med. 2017;196:e32-e47.
    PubMed     Text format     Abstract available


  31. AUSTIN ED, Hamid R
    Y Not? Sex Chromosomes May Modify Sexual Dimorphism in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2017 Oct 2. doi: 10.1164/rccm.201709-1865.
    PubMed     Text format    


  32. LIU D, Yan Y, Chen JW, Yuan P, et al
    Hypermethylation of BMPR2 Promoter Occurs in Patients with Heritable Pulmonary Arterial Hypertension and Inhibits BMPR2 Expression.
    Am J Respir Crit Care Med. 2017;196:925-928.
    PubMed     Text format    


    September 2017
  33. UMAR S, Cunningham CM, Itoh Y, Moazeni S, et al
    The Y Chromosome Plays a Protective Role in Experimental Hypoxic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2017 Sep 21. doi: 10.1164/rccm.201707-1345.
    PubMed     Text format    


  34. WILKINS MR
    Apoptosis Signal-regulating Kinase 1 Inhibition in Pulmonary Hypertension: Too Much to ASK?
    Am J Respir Crit Care Med. 2017 Sep 20. doi: 10.1164/rccm.201709-1814.
    PubMed     Text format    


  35. ACKERMANN M, Gaumann A, Mentzer SJ, Hinrichs JB, et al
    Plexiform Vasculopathy in Chronic Thromboembolic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2017 Sep 11. doi: 10.1164/rccm.201703-0591.
    PubMed     Text format    


    July 2017
  36. SWIFT AJ, Capener D, Johns C, Hamilton N, et al
    Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;196:228-239.
    PubMed     Text format     Abstract available


  37. ZIJLSTRA WMH, Ploegstra MJ, Vissia-Kazemier T, Roofthooft MTR, et al
    Physical Activity in Pediatric Pulmonary Arterial Hypertension Measured by Accelerometry. A Candidate Clinical Endpoint.
    Am J Respir Crit Care Med. 2017;196:220-227.
    PubMed     Text format     Abstract available


  38. MATHAI SC, Kawut SM
    Magnetic Resonance Imaging in Pulmonary Arterial Hypertension. Panacea or Pixelation?
    Am J Respir Crit Care Med. 2017;196:129-131.
    PubMed     Text format    


  39. AUSTIN ED, Feinstein JA
    Accelerometry: Improving Objective Assessments of Therapeutic Impact in Pediatric Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;196:127-129.
    PubMed     Text format    


    June 2017
  40. BARNES JW, Dweik RA
    Pulmonary Hypertension and Precision Medicine through the "Omics" Looking Glass.
    Am J Respir Crit Care Med. 2017;195:1558-1560.
    PubMed     Text format    


  41. NEWMAN JH, Rich S, Abman SH, Alexander JH, et al
    Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.
    Am J Respir Crit Care Med. 2017;195:1661-1670.
    PubMed     Text format     Abstract available


    May 2017

  42. Chronic Thromboembolic Pulmonary Hypertension: Part 1.
    Am J Respir Crit Care Med. 2017;195:P19-P20.
    PubMed     Text format    


  43. NICOLLS MR, Voelkel NF
    The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;195:1292-1299.
    PubMed     Text format    


    April 2017
  44. FERNANDES TM, Pretorius VG, Kim NH
    Caution Regarding Catheter-directed Thrombolysis: Chronic Thromboembolic Pulmonary Hypertension Mistaken for Acute Submassive Pulmonary Embolism.
    Am J Respir Crit Care Med. 2017;195:1066-1067.
    PubMed     Text format    


  45. CHIZINGA M, Rudkovskaia AA, Henderson K, Pollak J, et al
    Pulmonary Hypertension Prevalence and Prognosis in a Cohort of Patients with Hereditary Hemorrhagic Telangiectasia Undergoing Embolization of pAVMs.
    Am J Respir Crit Care Med. 2017 Apr 4. doi: 10.1164/rccm.201702-0267.
    PubMed     Text format    


  46. SA S, Gu M, Chappell J, Shao NY, et al
    Induced Pluripotent Stem Cell Model of Pulmonary Arterial Hypertension Reveals Novel Gene Expression and Patient Specificity.
    Am J Respir Crit Care Med. 2017;195:930-941.
    PubMed     Text format     Abstract available


  47. HAMID R, Yan L
    Induced Pluripotent Stem Cells in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;195:852-853.
    PubMed     Text format    


    March 2017
  48. GRAHAM BB, Koyanagi D, Kandasamy B, Tuder RM, et al
    Right Ventricle Vasculature in Human Pulmonary Hypertension Assessed by Stereology.
    Am J Respir Crit Care Med. 2017 Mar 9. doi: 10.1164/rccm.201702-0425.
    PubMed     Text format    


  49. BONNET S, Provencher S, Guignabert C, Perros F, et al
    Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;195:583-595.
    PubMed     Text format    


    February 2017
  50. HONG Z, Chen KH, DasGupta A, Potus F, et al
    MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.
    Am J Respir Crit Care Med. 2017;195:515-529.
    PubMed     Text format     Abstract available


  51. GUPTE SA, Wolin MS
    Mitochondrial Calcium Transport: A Potentially Prominent, Therapeutically Targetable Contributor to Pulmonary Arterial Hypertension Progression.
    Am J Respir Crit Care Med. 2017;195:420-421.
    PubMed     Text format    


  52. PULLAMSETTI SS, Savai R, Seeger W, Goncharova EA, et al
    Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs.
    Am J Respir Crit Care Med. 2017;195:425-437.
    PubMed     Text format    


  53. KAWUT SM, Archer-Chicko CL, DeMichele A, Fritz JS, et al
    Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial.
    Am J Respir Crit Care Med. 2017;195:360-368.
    PubMed     Text format     Abstract available


  54. BAILLIE TJ, Sidharta S, Steele PM, Worthley SG, et al
    Noninvasive Assessment of Cardiopulmonary Reserve: Toward Early Detection of Pulmonary Vascular Disease.
    Am J Respir Crit Care Med. 2017;195:398-401.
    PubMed     Text format    


  55. LEBERKUHNE LJ, Ploegstra MJ, Douwes JM, Bartelds B, et al
    Serially Measured Uric Acid Levels Predict Disease Severity and Outcome in Pediatric Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;195:401-404.
    PubMed     Text format    


  56. LAHM T, Frump AL
    Toward Harnessing Sex Steroid Signaling as a Therapeutic Target in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;195:284-286.
    PubMed     Text format    


    January 2017
  57. BRUSSELLE G, Bracke K, De Pauw M
    Peripheral Artery Disease in Patients with Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med. 2017;195:148-150.
    PubMed     Text format    


  58. GLADWIN MT
    Translational Advances in the Field of Pulmonary Hypertension Bench to Bedside: How Fundamental Discoveries in Science Are Advancing Our Understanding and Therapy of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;195:1-3.
    PubMed     Text format    


  59. AUSTIN ED, West J, Loyd JE, Hemnes AR, et al
    Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing.
    Am J Respir Crit Care Med. 2017;195:23-31.
    PubMed     Text format    


    November 2016
  60. MARON BA, Abman SH
    Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  61. KAMENY RJ, Fineman JR
    The Prescient Prognosticator? Hepatoma-derived Growth Factor in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2016;194:1186-1187.
    PubMed     Text format    


  62. KUEBLER WM
    Vascular Calcification in Pulmonary Hypertension. Another Brick in the Wall.
    Am J Respir Crit Care Med. 2016;194:1187-1189.
    PubMed     Text format    


  63. BERRA L, Rodriguez-Lopez J, Rezoagli E, Yu B, et al
    Electric Plasma-generated Nitric Oxide: Hemodynamic Effects in Patients with Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2016;194:1168-1170.
    PubMed     Text format    


    October 2016
  64. ABMAN SH, Ivy DD, Archer SL, Wilson K, et al
    Executive Summary of the American Heart Association and American Thoracic Society Joint Guidelines for Pediatric Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2016;194:898-906.
    PubMed     Text format     Abstract available


  65. BOUCHERAT O, Bonnet S, Paulin R
    The HIPPO-Thesis of Pulmonary HYPERtension.
    Am J Respir Crit Care Med. 2016;194:787-789.
    PubMed     Text format    


    September 2016
  66. CHUN HJ, Bonnet S, Chan SY
    Translating MicroRNA Biology in Pulmonary Hypertension: It Will Take More Than "miR" Words.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


    May 2016
  67. TOFOVIC SP, Jackson EK
    Estrogens in Men: Another Layer of Complexity of Estradiol Metabolism in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2016;193:1087-90.
    PubMed     Text format    


  68. WHITE RJ
    Estrogen: Friend or Foe in Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2016;193:1084-6.
    PubMed     Text format    


    April 2016
  69. KUDRYASHOVA TV, Goncharov DA, Pena A, Kelly N, et al
    HIPPO-integrin Linked Kinase Crosstalk Controls Self-sustaining Proliferation and Survival in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  70. YUNG LM, Nikolic I, Paskin-Flerlage SD, Pearsall RS, et al
    A Selective TGFbeta Ligand Trap Attenuates Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  71. NIKOLIC I, Yu PB
    The Role of Bone Marrow-derived Cells in Pulmonary Arterial Hypertension. What Lies Beneath?
    Am J Respir Crit Care Med. 2016;193:822-4.
    PubMed     Text format    


  72. YAN L, Chen X, Talati M, Nunley BW, et al
    Bone Marrow-derived Cells Contribute to the Pathogenesis of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2016;193:898-909.
    PubMed     Text format     Abstract available


  73. LIPTZIN DR, Sturgill M, Kim J, Abman SH, et al
    An Unusual Etiology of Infantile Hemoptysis.
    Am J Respir Crit Care Med. 2016;193:e14-5.
    PubMed     Text format    


    March 2016
  74. GALAMBOS C, Sims-Lucas S, Abman SH, Cool CD, et al
    Intrapulmonary Bronchopulmonary Anastomoses and Plexiform Lesions in Idiopathic Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2016;193:574-6.
    PubMed     Text format    


  75. ST CROIX CM, Steinhorn RH
    New Thoughts about the Origin of Plexiform Lesions.
    Am J Respir Crit Care Med. 2016;193:484-5.
    PubMed     Text format    


    November 2015
  76. VANDERPOOL RR, Naeije R
    Progress in Pulmonary Hypertension with Left Heart Failure. Beyond New Definitions and Acronyms.
    Am J Respir Crit Care Med. 2015;192:1152-4.
    PubMed     Text format    


    October 2015
  77. ATAYA A, Barretto J, Wynne J, Faruqi I, et al
    Beyond the Blue: Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2015.
    PubMed     Text format    


  78. GRUNIG G, Durmus N
    Spotlight on Inflammation in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2015;192:913-915.
    PubMed     Text format    


  79. TONELLI AR, Ahmed MK, Alkukhun L, Cikach F, et al
    Treprostinil Iontophoresis in Idiopathic Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2015;192:1014-6.
    PubMed     Text format    


  80. SINGER LG, Chowdhury NA, Faughnan ME, Granton J, et al
    Effects of Recipient Age and Diagnosis on Health-related Quality-of-Life Benefit of Lung Transplantation.
    Am J Respir Crit Care Med. 2015;192:965-73.
    PubMed     Text format     Abstract available


  81. PERROS F, Bonnet S
    Bone morphogenetic protein receptor type II and inflammation are bringing old concepts into the new pulmonary arterial hypertension world.
    Am J Respir Crit Care Med. 2015;192:777-9.
    PubMed     Text format    


    September 2015
  82. GONCHAROVA EA, Gladwin MT, Kawut SM
    Update in Pulmonary Vascular Diseases 2014.
    Am J Respir Crit Care Med. 2015;192:544-50.
    PubMed     Text format    


    August 2015
  83. DE JESUS PEREZ VA
    First among Equals: Nerve Growth Factor in the Pathogenesis of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2015;192:274-5.
    PubMed     Text format    


  84. RHODES CJ, Im H, Cao A, Hennigs JK, et al
    RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2015;192:356-66.
    PubMed     Text format     Abstract available


    July 2015
  85. SPIEKERKOETTER E, Sung YK, Sudheendra D, Bill M, et al
    Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2015;192:254-7.
    PubMed     Text format    


  86. VAN HOUTEN B
    Pulmonary Arterial Hypertension Is Associated with Oxidative Stress-induced Genome Instability.
    Am J Respir Crit Care Med. 2015;192:129-30.
    PubMed     Text format    


  87. FEDERICI C, Drake KM, Rigelsky CM, McNelly LN, et al
    Increased Mutagen Sensitivity and DNA Damage in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2015;192:219-28.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: